Device Trial Radar · NCT01226173
Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol
Last checked: Nov 20, 2026Latest source record: Sep 24, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
182,353
Actual
Start
Mar 2010
Primary completion
Aug 2012
Study completion Aug 2012
Sponsor
- Lead sponsor
- Bio-Rad LaboratoriesNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- American National Red Cross; Centers for Disease Control and Prevention
- First posted
- Oct 22, 2010
Design
- Study type
- Observational
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to screen blood donors for the presence of NS1 antigen of the dengue virus at the American Red Cross in Puerto Rico region (and Monroe County, Florida) using the Platelia Dengue NS1 Ag enzyme immunoassay.
Conditions
- Mass Screening
Interventions
Bio-Rad Platelia Dengue NS1 Ag testDevice
The purpose of the study is to screen blood donors for the presence of dengue NS1 antigen at the ARC in Puerto Rico region using the Bio-Rad Platelia Dengue NS1 Ag test.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of blood donors with repeatedly reactive Platelia Dengue NS1 Ag test results.Time frame: Two and a half years
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Community Blood Centers of Florida, Inc.
Lauderhill, Florida
American Red Cross
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.